Skip to content
10-Q

Quarterly Report

FULCRUM THERAPEUTICS, INC. FULC

0001193125-26-178814

← back to feed
Filed
Apr 27, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 20, 2026 66.63M sh
Shares Diluted Q1 2026 · Mar 31, 2026 76.22M sh
Shares Diluted Q1 2026 · Mar 31, 2025 62.48M sh
Capex Q1 2026 · Mar 31, 2026 $8K
Capex Q1 2026 · Mar 31, 2025 $0
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$18.75M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$15.26M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $50.26M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $197.53M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $42.18M
Stockholders Equity Q1 2026 · Mar 31, 2026 $333.3M
Stockholders Equity Q1 2026 · Dec 31, 2025 $349M
Stockholders Equity Q1 2026 · Mar 31, 2025 $228.49M
Stockholders Equity Q1 2026 · Dec 31, 2024 $243.03M
Current Liabilities Q1 2026 · Mar 31, 2026 $9.86M
Current Liabilities Q1 2026 · Dec 31, 2025 $13.05M
Total Liabilities Q1 2026 · Mar 31, 2026 $13.47M
Total Liabilities Q1 2026 · Dec 31, 2025 $17.28M
Current Assets Q1 2026 · Mar 31, 2026 $338.67M
Current Assets Q1 2026 · Dec 31, 2025 $357.48M
Total Assets Q1 2026 · Mar 31, 2026 $346.77M
Total Assets Q1 2026 · Dec 31, 2025 $366.28M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.25
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.28
Eps Basic Q1 2026 · Mar 31, 2026 −$0.25
Eps Basic Q1 2026 · Mar 31, 2025 −$0.28
Sga Expense Q1 2026 · Mar 31, 2026 $8.1M
Sga Expense Q1 2026 · Mar 31, 2025 $7M
Rd Expense Q1 2026 · Mar 31, 2026 $14.08M
Rd Expense Q1 2026 · Mar 31, 2025 $13.4M
Net Income Q1 2026 · Mar 31, 2026 −$18.89M
Net Income Q1 2026 · Mar 31, 2025 −$17.66M
Operating Income Q1 2026 · Mar 31, 2026 −$22.19M
Operating Income Q1 2026 · Mar 31, 2025 −$20.4M